Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Clinical trial NCT03356483 · COMPLETED

Trial details

NCT number: NCT03356483
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2018-11-13
Primary completion: 2024-07-25
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.